[Mechanism mediating hypertension induced by chronic inhibition of nitric oxide synthesis]. 1997

X Li, and S Yuasa, and H Hitomi, and M Hashimoto, and H Fujioka, and H Kiyomoto, and K Uchida, and T Shoji, and N Takahashi, and H Matsuo
Second Department of Internal Medicine, School of Medicine, Kagawa Medical University, Japan.

Although the inhibition of nitric oxide (NO) synthesis is known to induce systemic hypertension, the underlying mechanisms mediating this type of hypertension are incompletely understood. In the present study we investigated the influence of sodium intake on the pressor effect of long-term administration of the NO synthesis inhibitor, NG-nitro-L-arginine methyl ester (L-NAME, 16 mg/dl in drinking fluid for 8 weeks), in conscious Sprague-Dawley rats. Urinary excretion rates of catecholamine during NO synthesis inhibition were also examined. Long-term administration of L-NAME produced a sustained elevation in tail-cuff pressure without altering urine flow, or sodium excretion rate. L-NAME-induced hypertension was accompanied by a decreased urinary excretion of the stable NO metabolites, NO2- and NO3-, and was aggravated when rats drank 0.9% saline in place of tap water. Thus, inhibition of NO synthesis resulted in a rightward shift of the pressure natriuresis relationship and a significant decrease in the slope of this relationship. Urinary excretion of epinephrine and norepinephrine, but not that of dopamine, in L-NAME-treated rats significantly increased within the first week of the study when compared with those observed in control rats. A natriuretic index of the sympathetic nervous system, the ratio of dopamine to norepinephrine excretion, was significantly less in L-NAME-treated rats than in control rats. After 8-week treatment with L-NAME, renal morphologic evaluation revealed significant narrowing and obliteration of the arterioles. L-arginine (2 g/dl in drinking fluid) completely reversed the elevation of blood pressure as well as the decrease in urinary NO2- and NO3- excretion and the increased urinary excretion of catecholamines associated with L-NAME treatment after 3 weeks of concomitant administration. These results suggest that the inhibition of chronic NO synthesis produces sodium-sensitive hypertension and that changes in sympathetic nerve activity may, at least in part, contribute to the sodium sensitivity in this type of hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23
D012982 Sodium, Dietary Sodium or sodium compounds used in foods or as a food. The most frequently used compounds are sodium chloride or sodium glutamate. Dietary Sodium
D013564 Sympathetic Nervous System The thoracolumbar division of the autonomic nervous system. Sympathetic preganglionic fibers originate in neurons of the intermediolateral column of the spinal cord and project to the paravertebral and prevertebral ganglia, which in turn project to target organs. The sympathetic nervous system mediates the body's response to stressful situations, i.e., the fight or flight reactions. It often acts reciprocally to the parasympathetic system. Nervous System, Sympathetic,Nervous Systems, Sympathetic,Sympathetic Nervous Systems,System, Sympathetic Nervous,Systems, Sympathetic Nervous
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

X Li, and S Yuasa, and H Hitomi, and M Hashimoto, and H Fujioka, and H Kiyomoto, and K Uchida, and T Shoji, and N Takahashi, and H Matsuo
January 1998, Life sciences,
X Li, and S Yuasa, and H Hitomi, and M Hashimoto, and H Fujioka, and H Kiyomoto, and K Uchida, and T Shoji, and N Takahashi, and H Matsuo
December 1995, Hypertension research : official journal of the Japanese Society of Hypertension,
X Li, and S Yuasa, and H Hitomi, and M Hashimoto, and H Fujioka, and H Kiyomoto, and K Uchida, and T Shoji, and N Takahashi, and H Matsuo
June 1994, Hypertension (Dallas, Tex. : 1979),
X Li, and S Yuasa, and H Hitomi, and M Hashimoto, and H Fujioka, and H Kiyomoto, and K Uchida, and T Shoji, and N Takahashi, and H Matsuo
January 1995, Journal of hypertension,
X Li, and S Yuasa, and H Hitomi, and M Hashimoto, and H Fujioka, and H Kiyomoto, and K Uchida, and T Shoji, and N Takahashi, and H Matsuo
September 1994, Hypertension (Dallas, Tex. : 1979),
X Li, and S Yuasa, and H Hitomi, and M Hashimoto, and H Fujioka, and H Kiyomoto, and K Uchida, and T Shoji, and N Takahashi, and H Matsuo
September 2001, Surgery,
X Li, and S Yuasa, and H Hitomi, and M Hashimoto, and H Fujioka, and H Kiyomoto, and K Uchida, and T Shoji, and N Takahashi, and H Matsuo
October 1999, Clinical and experimental hypertension (New York, N.Y. : 1993),
X Li, and S Yuasa, and H Hitomi, and M Hashimoto, and H Fujioka, and H Kiyomoto, and K Uchida, and T Shoji, and N Takahashi, and H Matsuo
January 2000, Clinical hemorheology and microcirculation,
X Li, and S Yuasa, and H Hitomi, and M Hashimoto, and H Fujioka, and H Kiyomoto, and K Uchida, and T Shoji, and N Takahashi, and H Matsuo
September 1992, Hypertension (Dallas, Tex. : 1979),
X Li, and S Yuasa, and H Hitomi, and M Hashimoto, and H Fujioka, and H Kiyomoto, and K Uchida, and T Shoji, and N Takahashi, and H Matsuo
October 1995, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!